M1367 HCPCS Level II code: Quality care for the treatment of ear, nose, and throat disorders mips value pathway
M1367 is the HCPCS code for “Quality care for the treatment of ear, nose, and throat disorders mips value pathway” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
M1367Quality care for the treatment of ear, nose, and throat disorders mips value pathway
Short description: Qual care ent disorder mvp
HCPCS · United States
Medicare details
The indicators CMS publishes with M1367 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Undefined codes
- Added
- Jan 1, 2024
Where M1367 sits
- 1M codesMedical services and quality measures
- 2Active code M1367Quality care for the treatment of ear, nose, and throat disorders mips value pathway
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code M1367 mean?
M1367 is the HCPCS code for “Quality care for the treatment of ear, nose, and throat disorders mips value pathway” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover M1367?
CMS lists M1367’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside M1367
All M codesM1361Suicide risk based on their clinician's evaluation or a clinician-rated toolM1362Patients who died during the measurement periodM1363Patients who did not have a follow-up assessment within 120 days of the index assessmentM1364Calculated 10-year ascvd risk score of >= 20 percent during the performance periodM1365Patient encounter during the performance period with hospice and palliative care specialty code 17M1366Focusing on women's health mips value pathwayM1368Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathwayM1369Quality care in mental health and substance use disorders mips value pathwayM1370Rehabilitative support for musculoskeletal care mips value pathwayM1371Most recent glycemic status assessment (hba1c or gmi) level < 7.0%M1372Most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0%M1373Most recent glycemic status assessment (hba1c or gmi) level >= 8.0% and <= 9.0%